CC BY-NC-ND 4.0 · South Asian J Cancer 2022; 11(01): 046-051
DOI: 10.1055/s-0041-1740601
Original Article
Head and Neck Cancer

A Study of Head and Neck Cancer Patients with Reference to Tobacco Use, Gender, and Subsite Distribution

Richa Chauhan
1   Department of Radiotherapy, Mahavir Cancer Sansthan, Patna, Bihar, India
,
Vinita Trivedi
1   Department of Radiotherapy, Mahavir Cancer Sansthan, Patna, Bihar, India
,
Rita Rani
1   Department of Radiotherapy, Mahavir Cancer Sansthan, Patna, Bihar, India
,
Usha Singh
1   Department of Radiotherapy, Mahavir Cancer Sansthan, Patna, Bihar, India
› Author Affiliations

Abstract

Zoom Image
Richa Chauhan

Context Head and neck cancer (HNC) is very common in India, constituting 30% of all the cancers because of the widespread use of tobacco across India. The prevalence and pattern of tobacco use vary in different regions and states of the country. Although predominantly seen in males, studies have reported that the male-to-female ratio varies worldwide and also by anatomical subsite.

Aims This study was done with an aim to determine the difference in pattern and prevalence of tobacco use in male and female patients with HNCs and compare them with different subsites' involvement in our region.

Methods and Materials This is a retrospective analysis of 500 consecutive biopsy-proven HNC patients from a large comprehensive cancer hospital from Bihar during the period of January 2019 to June 2019. Data collected for the study included age, gender, site of the disease, and use of tobacco. The categorical data were analyzed by a chi-square test using SPSS (version 16).

Results Our study showed a male-to-female ratio of 8.43:1 with tobacco addiction in 84.40% patients. Smokeless tobacco was used by 52.20%, combustible form by 12.80%, and both by 19.40% of the patients. Tobacco use was seen in 87.25% of male patients as compared with only 60.38% of female patients (p-value = 0.0001). Oral cavity cancer was seen in 60.85% of male patients and 37.74% of female patients (p-value = 0.0012), whereas oropharyngeal cancer was seen in only 11.63% of male patients as compared with 25.83% of female patients (p-value = 0.0008). The subsite analysis showed that in patients with oral cavity cancers, no addiction was found in only 10.29% of male patients as compared with 30% of the female patients (p-value = 0.008).

Conclusions Our study confirms a high prevalence of tobacco use among HNC patients. So, we need to continue our efforts to create awareness against tobacco use. Besides, there is also a need for more studies to look into other etiological factors among nontobacco users.

Source(s) of Support

Nil.




Publication History

Article published online:
02 February 2022

© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
  • 2 NCI. Head and neck cancer. United States National Cancer Institute, National Institutes of Health 2018. Accessed March 22, 2021: www.cancer.gov/types/head-and-neck/head-neck-fact-sheet
  • 3 Masud D, Gilbert P. Secure sterile head drape for head and neck surgery. J Plast Reconstr Aesthet Surg 2009; 62 (01) 143-144
  • 4 Kulkarni MK. Head and neck cancer burden in India. Int J Head Neck Surg 2013; 4: 29-35
  • 5 Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol 2008; 9 (07) 667-675
  • 6 Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med 1982; 306 (19) 1151-1155
  • 7 Available at: WHO. Global Adult Tobacco Survey India; 2016–17. Accessed March 22, 2021: www.who.int/tobacco/surveillance/survey/gats/ GATS_India_2016-17_FactSheet.pd. Accessed on December 10, 2021
  • 8 Addala L, Pentapati CK, Reddy Thavanati PK, Anjaneyulu V, Sadhnani MD. Risk factor profiles of head and neck cancer patients of Andhra Pradesh, India. Indian J Cancer 2012; 49 (02) 215-219
  • 9 Reddy KS, Gupta PC. eds. Report on Tobacco Control in India. New Delhi, India: Ministry of Health and Family Welfare, Government of India; 2004
  • 10 Adhikari A, De M. Toxic effects of betel quid. Int J Hum Genet 2013; 13: 7-14
  • 11 Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008; 10 (12) 1773-1782
  • 12 Kumar A, Sharma A, Ahlawat B, Sharma S. Site specific effect of tobacco addiction in upper aerodigestive tract tumors: a retrospective clinicopathological study. ScientificWorldJournal 2014; 2014: 460194
  • 13 Malik A, Mishra A, Garg A. et al. Trends of oral cancer with regard to age, gender, and subsite over 16 years at a tertiary cancer center in India. Indian J Med Paediatr Oncol 2018; 39: 297-300
  • 14 Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol 2011; 23 (08) 633-641
  • 15 Das R, Kataki AC, Sharma JD, Baishya N, Kalita M, Krishnatreya M. A study of head and neck cancer patients with special reference to tobacco use and educational level. Clin Cancer Investig J 2017; 6: 21-25
  • 16 Pandey A, Singh A, Singh S. et al. Oral smokeless tobacco consumption pattern among rural Indian cancer patients: a prospective survey. South Asian J Cancer 2020; 9 (01) 17-19
  • 17 Kenborg L, Jørgensen AD, Budtz-Jørgensen E, Knudsen LE, Hansen J. Occupational exposure to the sun and risk of skin and lip cancer among male wage earners in Denmark: a population-based case-control study. Cancer Causes Control 2010; 21 (08) 1347-1355
  • 18 IARC. List of classifications: agents classified by the IARC Monographs, Volumes 1–124”. IARC Monographs on the Evaluation of Risk to Humans. IARC 2019
  • 19 Ologe FE, Adeniji KA, Segun-Busari S. Clinicopathological study of head and neck cancers in Ilorin, Nigeria. Trop Doct 2005; 35 (01) 2-4
  • 20 Jethwa AR, Khariwala SS. Tobacco-related carcinogenesis in head and neck cancer. Cancer Metastasis Rev 2017; 36 (03) 411-423
  • 21 Zhou J, Michaud DS, Langevin SM, McClean MD, Eliot M, Kelsey KT. Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England. Int J Cancer 2013; 132 (08) 1911-1917
  • 22 Ng M, Freeman MK, Fleming TD. et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014; 311 (02) 183-192
  • 23 Siddiqi K, Shah S, Abbas SM. et al. Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries. BMC Med 2015; 13: 194
  • 24 Coelho KR. Challenges of the oral cancer burden in India. J Cancer Epidemiol 2012; 2012: 701932
  • 25 Goud ML, Mohapatra SC, Mohapatra P, Gaur SD, Pant GC, Knanna MN. Epidemiological correlates between consumption of Indian chewing tobacco and oral cancer. Eur J Epidemiol 1990; 6 (02) 219-222
  • 26 Pednekar MS, Gupta PC, Yeole BB, Hébert JR. Association of tobacco habits, including bidi smoking, with overall and site-specific cancer incidence: results from the Mumbai cohort study. Cancer Causes Control 2011; 22 (06) 859-868
  • 27 Agrawal S, Karan A, Selvaraj S, Bhan N, Subramanian SV, Millett C. Socio-economic patterning of tobacco use in Indian states. Int J Tuberc Lung Dis 2013; 17 (08) 1110-1117
  • 28 Sinha DN, Gupta PC, Pednekar MS. Tobacco use in a rural area of Bihar, India. Indian J Community Med 2003; 28: 167-170
  • 29 Khariwala SS, Hatsukami D, Hecht SS. Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators. Head Neck 2012; 34 (03) 441-447
  • 30 Basu R, Mandal S, Ghosh A, Poddar TK. Role of tobacco in the development of head and neck squamous cell carcinoma in an eastern Indian population. Asian Pac J Cancer Prev 2008; 9 (03) 381-386
  • 31 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90: 1-636
  • 32 de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141 (04) 664-670
  • 33 Toner M, O'Regan EM. Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 1. Head Neck Pathol 2009; 3 (03) 246-248
  • 34 Sturgis EM, Wei Q. Genetic susceptibility–molecular epidemiology of head and neck cancer. Curr Opin Oncol 2002; 14 (03) 310-317
  • 35 Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 2008; 30 (01) 75-84